Abstract
Introduction
The purpose of this study was to evaluate the long-term effects of chitosan 0.1% and sodium hyaluronate 1.4% (Healon GV®; Advanced Medical Optics, Santa Ana, CA, USA) on intraocular pressure (IOP) and endothelial cell loss.
Methods
This randomised study comprised 140 eyes of 140 patients with age-related cataracts undergoing phacoemulsification followed by posterior chamber intraocular lens (IOL) implantation; 70 received chitosan 0.1%, and 70 received sodium hyaluronate 1.4%. The IOP was measured with standard Goldman applanation tonometry pre-operatively and 1 day, 1 week, 1 month, 3 months, 1 year and 3 years postoperatively. Endothelial cell counts were performed pre-operatively and 1 week, 1 month, 3 months, 1 year and 3 years postoperatively using a Pro/Koester WFSCM contact endothelial microscope.
Results
There were no significant differences found in postoperative IOP levels among the chitosan and sodium hyaluronate groups (P>0.05). No significant differences were found in postoperative mean endothelial cell counts at all time points between the chitosan and sodium hyaluronate groups (P>0.05).
Conclusion
Chitosan has the same effects as sodium hyaluronate on IOP and endothelium cells counts after cataract surgery and IOL implantation, and therefore may be an alternative ophthalmic viscoelastic device.
Similar content being viewed by others
References
Kelman CD. Symposium: phacoemulsification. History of emulsification and aspiration of senile cataracts. Trans Am Acad Ophthalmol Otolaryngol. 1974;78:OP5–OP13.
Alpar JJ. Viscoelastic surgery. Ann Ophthalmol. 1987;19:350–353.
Bourne WM, Liesegang TJ, Waller RR, Ilstrup DM. The effect of sodium hyaluronate on endothelial cell damage during extracapsular cataract extraction and posterior chamber lens implantation. Am J Ophthalmol. 1984;98:759–762.
Musch DC, Meyer RF, Sugar A, Soong HK. Endothelial rejection following penetrating keratoplasty using Healon or BSS. Cornea. 1990;9:305–311.
Alpar JJ. Use of Healon in different cataract surgery techniques: endothelial cell count study. Ophthalmic Surg. 1987;18:529–531.
Fry LL. Postoperative intraocular pressure rises: a comparison of Healon, Amvisc, and Viscoat. J Cataract Refract Surg. 1989;15:415–420.
Liesegang TJ. Viscoelastic substances in ophthalmology. Surv Ophthalmol. 1990;34:268–293.
Li Y, Zhou Y, Hou C. Experimental study on intraocular use of chitosan. J Second Military Med Univ. 1997;18:455–457.
Felt O, Furrer P, Mayer JM, Plazonnet B, Buri P, Gurny R. Topical use of chitosan in ophthalmology: tolerance assessment and evaluation of precorneal retention. Int J Pharm. 1999;180:185–193.
Shigemasa Y, Minami S. Applications of chitin and chitosan for biomaterials. Biotechnol Genet Eng Rev. 1996;13:383–420.
Sall KN, Kreter JK, Keates RH. The effect of chitosan on corneal wound healing. Ann Ophthalmol. 1987;19:31–33.
Felt O, Carrel A, Baehni P, Buri P, Gurny R. Chitosan as tear substitute: a wetting agent endowed with antimicrobial efficacy. J Ocul Pharmacol Ther. 2000;16:261–270.
Alonso MJ, Sanchez A. The potential of chitosan in ocular drug delivery. J Pharm Pharmacol. 2003;55:1451–1463.
Enriquez de Salamanca A, Diebold Y, Calonge M, et al. Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance. Invest Ophthalmol Vis Sci. 2006;471:1416–1425.
Chen J, Li Q, Xu J, et al. Study on biocompatibility of complexes of collagenchitosan-sodium hyaluronate and cornea. Artif Organs. 2005;29:104–113.
Oztürk E, Ergün MA, Oztürk Z, et al. Chitosan-coated alginate membranes for cultivation of limbal epithelial cells to use in the restoration of damaged corneal surfaces. Int J Artif Organs. 2006;29:228–238.
You L, Yunqiu Z, Chunlin H. The clinical effects of chitosan in cataract surgery and intraocular lens implantation. J Inj Occup Dis Eye Ophthalmic Surg. 1999;21:541–543.
Morgan RK, Skuta GL. Viscoelasticrelated glaucomas. Semin Ophthalmol. 1994;9:229–234.
Balazs EA, Freeman MI, Klöti R, Meyer-Schwickerath G, Regnault F, Sweeney DB. Hyaluronic acid and replacement of vitreous and aqueous humor. Mod Probl Ophthalmol. 1972;10:3–21.
Dick HB, Krummenauer F, Augustin AJ, Pakula T, Pfeiffer N. Healon5 viscoadaptive formulation: comparison to Healon and Healon GV. J Cataract Refract Surg. 2001;27:320–326.
Tetz MR, Holzer MP, Lundberg K, Auffarth GU, Burk RO, Kruse FE. Clinical results of phacoemulsification with the use of Healon5 or Viscoat. J Cataract Refract Surg. 2001;27:416–420.
Schwenn O, Dick HB, Krummenauer F, Christmann S, Vogel A, Pfeiffer N. Healon5 versus Viscoat during cataract surgery: intraocular pressure, laser flare and corneal changes. Graefes Arch Clin Exp Ophthalmol. 2000;238:861–867.
Holzer MP, Tetz MR, Auffarth GU, Welt R, Volcker HE. Effect of Healon5 and 4 other viscoelastic substances on intraocular pressure and endothelium after cataract surgery. J Cataract Refract Surg. 2001;27:213–218.
Arshinoff S. The physical properties of ophthalmic viscoelastics in cataract surgery. Ophthalmic Pract. 1991;9:81–86.
Hütz WW, Eckhardt HB, Kohnen T. Comparison of viscoelastic substances used in phacoemulsification. J Cataract Refract Surg. 1996;22:955–959.
Dick B, Schwenn O, Pfeiffer N. Classification of viscoelastic substances for ophthalmologic surgery. Ophthalmologe. 1999;96:193–211.
Rizzuti AB. Cryosurgical cataract extraction under the operating microscope. Int Ophthalmol Clin. 1967;7:347–350.
Author information
Authors and Affiliations
Corresponding author
Additional information
You Li and Jin-Wei Cheng contributed equally to this work.
Rights and permissions
About this article
Cite this article
Li, Y., Cheng, JW., Wei, RL. et al. Intraocular pressure and endothelium cell counts after cataract surgery with chitosan and sodium hyaluronate (Healon GV): 3-Year follow-up results of a randomised clinical trial. Adv Therapy 25, 422–429 (2008). https://doi.org/10.1007/s12325-008-0059-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12325-008-0059-1